Further evidence for the lymphocytic nature of leukaemic reticuloendotheliosis (hairy-cell leukaemia).
D000135:Acid Phosphatase / Q000032:analysis; D001772:Blood Cell Count; D002699:Chlorambucil / Q000627:therapeutic use; D005455:Fluorescent Antibody Technique; D006651:Histocytochemistry; D006801:Humans; D006942:Hypergammaglobulinemia; D007072:Immunoglobulin D / Q000032:analysis; D007073:Immunoglobulin E / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007136:Immunoglobulins / Q000096:biosynthesis; D037102:Lectins / Q000494:pharmacology; D007938:Leukemia / Q000188:drug therapy / Q000532:radiotherapy*; D007962:Leukocytes / Q000187:drug effects; D008206:Lymphatic Diseases / Q000188:drug therapy / Q000532:radiotherapy*; D008214:Lymphocytes; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D011517:Prothrombin Time; D013163:Splenomegaly; D013667:Technetium; D014527:Uric Acid / Q000097:blood
D007072:Immunoglobulin D; D007075:Immunoglobulin M; D007136:Immunoglobulins; D037102:Lectins; D002699:Chlorambucil; D014527:Uric Acid; D007073:Immunoglobulin E; D013667:Technetium; D000135:Acid Phosphatase